Initial Treatment of Meningococcal Meningitis: Urgent First-Line Approach
Meningococcal meningitis is a medical emergency requiring immediate clinical action.
Time to treatment is a critical determinant of outcome — antibiotic therapy must not be delayed.
Clinical Context
This protocol addresses first-line management of suspected meningococcal meningitis.
Local resistance epidemiology and susceptibility testing results guide antibiotic selection,
and adjunctive anti-inflammatory therapy is considered alongside antibiotics from the outset.
Treatment Approach (partial overview)
The cornerstone of management is urgent intravenous antibiotic therapy — initiated within
one hour of presentation — with a third-generation cephalosporin indicated when
penicillin-resistant strains are suspected based on local epidemiology.
Adjunctive corticosteroid therapy is incorporated starting with the first antibiotic dose.
Specific agents, dosing, duration, and the full clinical algorithm are in the complete protocol below.
References
- It is strongly recommended to start antibiotic therapy as soon as possible in acute bacterial meningitis patients. The time period until antibiotics are administered should not exceed 1 hour.
- Therefore, patients with suspected meningococcal meningitis caused by bacterial strains that on the basis of the local epidemiology are likely to be resistant to penicillin, a third-generation cephalosporin should be provided until in vitro susceptibility testing is performed.
- Therefore, it is advised to start dexamethasone with the first dose of antibiotics.
- Empiric treatment with dexamethasone is strongly recommended for all adults and children with acute bacterial meningitis in the setting of high-income countries.
DOI: 10.1016/j.cmi.2016.01.007
View source ↗